Spiro heterocyclic compound and application thereof
The invention discloses a spiroheterocyclic compound with a structure as shown in a formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a deuterated compound or a prodrug molecule of the spiroheterocyclic compound, and application of the spiroheterocyclic compound or the pharmaceu...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a spiroheterocyclic compound with a structure as shown in a formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a deuterated compound or a prodrug molecule of the spiroheterocyclic compound, and application of the spiroheterocyclic compound or the pharmaceutically acceptable salt or the stereoisomer or the deuterated compound or the prodrug molecule. The compound has an effect of antagonizing the activity of an MC4 receptor, can be used for treating various diseases related to the MC4 receptor, and has a relatively high application value. # imgabs0 #
本发明公开了具有式(I)所示结构的螺杂环化合物或者其药学上可接受的盐或者其立体异构体或者其氘代物或者其前药分子,及其应用。该类化合物具有拮抗MC4受体活性的作用,可用于治疗与MC4受体相关的多种疾病,有较大的应用价值。#imgabs0# |
---|